Please login to the form below

Lighthouse Medical Communications US makes the list of finalists for the 2018 PM360 Trailblalzer Awards

Lighthouse Medical Communications US, part of the award-winning Lucid Group of companies, is delighted to announce that their ACT on Anemia campaign, developed in collaboration with the American Kidney Fund, has been named as a PM360 2018 Trailblazer Initiative Award Finalist for Best Patient/Consumer Education.

This exciting news is a true testament to the American Kidney Fund’s commitment to improving the lives of patients with chronic kidney disease.  ACT on Anemia was one of a small number of campaigns selected in its category. Finalists were selected by the PM360 Editorial Advisory Board, which is comprised of some of the most forward-thinking leaders in their respective fields. Entries are judged on: ability to overcome challenges; skill, innovation, and quality of planning and execution; and the effectiveness of the work.

ACT on Anemia - Anemia in Chronic Kidney Disease, is a multi-channel patient campaign, designed to help tackle the issue of anemia in patients with kidney disease by encouraging Awareness, Communication and Treatment. The campaign has already touched hundreds of thousands of lives via multiple on and off-line patient resources and tools, which has been complimented with an outreach medical education programme for healthcare professionals.

Ify Onyeaso, Business Unit Director, Lighthouse Medical Communications US, commented, “We are thrilled our campaign ACT on Anemia has been recognized by such a prestigious panel of Judges. At Lighthouse, we have a talent for working together with our clients to build the best and transform the lives of those we touch. Our passion, drive and collaborative approach enables us to create magical campaigns. Working with the American Kidney Fund to develop ACT on Anemia is a great example of this.”

This year’s awards will be announced at a gala on September 13th at Gotham Hall, New York City. The winners will be featured in the October issue of the magazine.

You can also follow the awards real-time on Twitter at:

12th September 2018



Company Details

Lucid Group Communications Limited

0345 0536671

Contact Website

First Floor, Jubilee House
Third Avenue
Globe Park

Latest content on this profile

My Lucid journey from PMW to Head of Medical
Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced and demanding industry, but one which offers enviable flexibility, variety and intellectual challenge. Leading agency Lucid Group prides itself on the many growth and development opportunities it offers its people. In this article, Katherine Duxbury, Lucid’s Head of Medical, reflects upon her own bespoke working journey over the past 12 years and explains how creativity, collaboration and a passion for science have led to a rewarding, stimulating and self-curated career.
Lucid Group Communications Limited
Listen, learn and lift off

Lucid Group Communications Limited
Launch excellence

Lucid Group Communications Limited
Meet The Lucid Group Talent Team
Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your career to the next level with us, you can be assured that you'll have a whole group of people here cheering you on.So, if you’re feeling stuck or unfulfilled in your current role and looking for a company that will provide the personal and career development you need, please check out our open roles here: contact one of our talent acquisition managers for a chat:Ellen Field Assoc CIPDElaine DowneyJon TurnerDaniel Newbury
Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)

Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)
In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so important?Because 300 million people worldwide are living with a rare disease. This means that, collectively, the number of people living with a rare disease is equivalent to the population of the world's third-largest country (USA).While we have come a long way since the inception of Rare Disease Day, there's still plenty of work to do.Part 2 of this series focuses on important topics including the role of technology and the opportunities it presents for the rare disease community. The panel also hold captivating insights on how the pandemic has impacted the use of related digital technologies, the role of gene therapy, the major challenges and successes for pharma companies in supporting the rare disease community over the last 13 years, and much, much more.If you’d like to know more about the work we do in rare diseases or would like advice on any healthcare communication challenges please get in touch with Clare Reynolds on LinkedIn or by email: clare.reynolds@wearelucidgroup.comAbout Lucid GroupFounded in 2007, Lucid Group is a global multi-capability healthcare consultancy with core expertise in medical strategy, healthcare communications, creative and brand strategy, motion, digital and technology, behaviour change, metrics, and data analytics.  We partner with the pharma and biotech industry, delivering life-transforming value with connected capabilities to create pioneering solutions that change behaviour, improve clinical practice and advance health outcomes.  Transforming lives. Always.
Lucid Group Communications Limited